Correlation Between Implantica and NextCell Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Implantica and NextCell Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Implantica and NextCell Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Implantica AG and NextCell Pharma AB, you can compare the effects of market volatilities on Implantica and NextCell Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Implantica with a short position of NextCell Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Implantica and NextCell Pharma.

Diversification Opportunities for Implantica and NextCell Pharma

-0.3
  Correlation Coefficient

Very good diversification

The 3 months correlation between Implantica and NextCell is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Implantica AG and NextCell Pharma AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NextCell Pharma AB and Implantica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Implantica AG are associated (or correlated) with NextCell Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NextCell Pharma AB has no effect on the direction of Implantica i.e., Implantica and NextCell Pharma go up and down completely randomly.

Pair Corralation between Implantica and NextCell Pharma

Assuming the 90 days trading horizon Implantica AG is expected to generate 0.35 times more return on investment than NextCell Pharma. However, Implantica AG is 2.84 times less risky than NextCell Pharma. It trades about 0.01 of its potential returns per unit of risk. NextCell Pharma AB is currently generating about 0.0 per unit of risk. If you would invest  4,005  in Implantica AG on September 1, 2024 and sell it today you would lose (395.00) from holding Implantica AG or give up 9.86% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Implantica AG  vs.  NextCell Pharma AB

 Performance 
       Timeline  
Implantica AG 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Implantica AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
NextCell Pharma AB 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in NextCell Pharma AB are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, NextCell Pharma unveiled solid returns over the last few months and may actually be approaching a breakup point.

Implantica and NextCell Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Implantica and NextCell Pharma

The main advantage of trading using opposite Implantica and NextCell Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Implantica position performs unexpectedly, NextCell Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NextCell Pharma will offset losses from the drop in NextCell Pharma's long position.
The idea behind Implantica AG and NextCell Pharma AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Commodity Directory
Find actively traded commodities issued by global exchanges
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital